Table 1

Demographic characteristics with significant differences between HRVO versus BRVO and HRVO versus CRVO in bold (p<0.05)

HRVOBRVOP value
(vs HRVO)
CRVOP value
(vs HRVO)
Eyes, n79590344
Patients, n78580344
Gender, % female48510.75410.31
Age, mean years (SD)71 (11)70 (11)0.5370 (12)0.68
VA, mean letters (SD)53.8 (17.7)59.4 (14.9)0.00951.9 (18.7)0.40
 VA ≥70 letters, %24320.15210.54
 VA ≤35 letters, %2090.007220.88
CST, mean microns (SD)550 (186)482 (159)0.004630 (223)0.002
Initial treatment
Bevacizumab33%32%0.9026%0.27
Ranibizumab37%39%0.7141%0.52
Aflibercept30%29%0.7932%0.79
  • P values reflect comparison of HRVO versus BRVO or comparison of HRVO versus CRVO.

  • BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; CST, central subfield thickness; HRVO, hemiretinal vein occlusion; VA, visual acuity.